Filing Flows › Orthofix Medical (OFIX) › Guidance & outlook
Orthofix Medical (OFIX) guidance and outlook
Orthofix Medical (OFIX) updated its guidance on Nov 9, 2026: Revenue (segment) $825M–$830M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $825M–$830M | new |
From the earnings release filed Nov 9, 2026 (8-K on EDGAR).
Orthofix Medical's latest quarter
Orthofix Medical, Q3 FY26: revenue $208M (+1% year over year), operating margin 0.7%, net loss $6.1M, operating cash flow $363K. The chart follows the revenue to costs, profit and cash.
Questions
Did Orthofix Medical raise or lower its guidance?
Orthofix Medical (OFIX) updated its guidance on Nov 9, 2026: Revenue (segment) $825M–$830M for FY2026.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.